Tag: 上海千花网坊1001

Tokyo stocks close lower after Trump-Biden debate

first_imgTokyo stocks closed lower on Wednesday after the first US presidential debate between Democrat Joe Biden and President Donald Trump, which turned into a shouting match.The benchmark Nikkei 225 index fell 1.50 percent or 353.98 points to end at 23,185.12, while the broader Topix index dropped 1.97 percent or 32.61 points to 1,625.49.”After the presidential debate, concerns over a (potential) political vacuum due to issues around Mr Trump caused falls in US features, with the Nikkei slipping further,” Okasan Online Securities chief strategist Yoshihiro Ito said in a commentary. Telecom operator NTT closed down 3.60 percent at 2,150 yen, a day after it announced a takeover of its mobile phone unit on concerns the deal could have negative impact on NTT’s financial conditions.Its phone unit NTT Docomo climbed 20.91 percent to 3,885 yen, near the 3,900 yen price NTT will pay in the deal.Its smaller rival and wireless newcomer Rakuten was up 0.89 percent at 1,132 yen. After the market close it announced a 5G wireless service at a much cheaper price than domestic rivals. Among other major shares, Toyota was down 2.54 percent at 6,932 yen, Uniqlo casual wear operator Fast Retailing was down 0.36 percent at 65,860 yen, and Sony ended down 2.04 percent at 8,032 yen.The dollar fetched 105.49 yen in Asian trade, against 105.68 yen in New York late Tuesday.Topics :last_img read more

Read more…

Drug firms cut vaccine prices to the developing world

first_img Sharing is caring! Tweet Share HealthLifestyle Drug firms cut vaccine prices to the developing world by: – June 6, 2011 Sharecenter_img 30 Views   no discussions Share The vaccines will be sold at a price that covers the drugmakers’ costsSeveral major drugs companies have announced big cuts to the amounts they charge for their vaccines in the developing world.GlaxoSmithKline (GSK), Merck, Johnson & Johnson and Sanofi-Aventis have agreed to cut prices through the international vaccine alliance Gavi.GSK said it would cut the price of its vaccine for rotavirus by 67% to $2.50 (£1.50) a dose in poor countries.Rotavirus-related diarrhoea kills more than 500,000 children a year.The vaccine will be subsidised by higher prices being charged in richer countries.The rotavirus vaccine, for example, would cost about $50 in the US.‘Helped out’“What we need is a return to invest in the next generation of new vaccines and drugs and that has to come from the profits of the medicines or the vaccines,” Andrew Witty, chief executive of GSK told the BBC.“But it’s obvious that if you’re in Kenya or a slum in Malawi or somewhere like that there is no capacity for those people to contribute to it, so they have to be helped out by the contribution from the middle and the richer (countries).”Gavi is a partnership representing public and private sector organisations that helps to fund mass vaccination programmes in developing countries.It is committed to funding the introduction of rotavirus vaccinations in 40% of the poorest countries by 2015, but it faced a $3.7bn funding shortfall and so has been appealing for price cuts and donations.It will be holding a pledging conference in London on 13 June.Anti-poverty campaigners welcomed the move but also called on world leaders to act.“The pricing commitments announced today help drive momentum, but Gavi’s ambition to save four million lives in the next five years is only achievable if the international donor community steps up to the plate on 13 June,” said Jamie Drummond, executive director of campaign group ONE.Malaria vaccineMerck has said it will provide its own rotavirus vaccine for $5 a dose, coming down to $3.50 once more than 30 million doses have been sold.The price Gavi pays for pentavalent vaccines, which protect against diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type B will be cut by two Indian firms, Serum Institute and Panacea Biotec.GSK also said it was very close to developing the world’s first malaria vaccine, which is unusual because there is no market for it in the West.That means there is no opportunity for patients in richer countries to subsidise those in poorer countries.As a result, GSK said that if the vaccine comes to market it would be sold at a price that provides a small return of 5%, which would be used to fund the next generation of malaria treatments.Save the Children called on other companies to replicate the “landmark move” which it said could prevent hundreds of thousands of “needless deaths”.“It’s important that Gavi now uses this to spur other vaccine producers to reduce prices and work to foster greater competition amongst producers to drive prices down even further and help even more children,” said chief executive Justin Forsyth.BBC Newslast_img read more

Read more…

EPL Wednesday: Arsenal steeled for Anfield exam

first_imgArsene Wenger says Arsenal will face a stern test of their Premier League title credentials when they take on Liverpool on Wednesday.Wenger’s side head to Anfield two points clear at the head of the table and having won five of their last six league games.The weekend FA Cup third round victory over Sunderland extended their winning run and Wenger acknowledges his side’s recent success has strengthened the belief they can push on during the second half of the season.The Gunners manager, though, knows any meeting with Liverpool carries an extra edge that was demonstrated when the sides met on Merseyside last season, with the home side clinching a point thanks to Martin Skrtel’s stoppage-time equaliser.”The momentum creates confidence and confidence is vital at that level,” Wenger said.”In December and now in January we have been consistent and we go into a very important part of the season because we play many games. “Every time we go to Anfield, we face a team who is up for it. It’s always a ferocious battle, no matter who the manager is.”They had a very strong manager before, they have a very strong one now and Jurgen Klopp has the personality to do well there.”Wenger hopes to add Basle midfielder Mohamed Elneny to his squad this week.”I expect Mohamed yes, we are positive that this week it can happen,” he said.And his options will shortly be strengthened by the return to fitness of Alexis Sanchez, although the Chile striker will not make the trip to Liverpool. “We think he will be short for Wednesday,” said Wenger.”He has a chance to be available for Sunday against Stoke. He is always keen to play.”BIG CHALLENGELiverpool manager Jurgen Klopp is looking forward rather than back as he prepares to take on Wenger in English football for the first time.The pair have previously met at Champions League level with honours almost even, Wenger enjoying three wins to Klopp’s two and a draw from his time in charge at Bundesliga side Borussia Dortmund. Klopp took over at Liverpool after the sides had drawn 0-0 at the Emirates Stadium in the Premier League in August.And the German admits watching Wenger’s work at closer quarters has impressed him even more as the Liverpool boss prepares for huge back-to-back home games against the Gunners and Manchester United.”We shouldn’t talk too much about my experiences of playing against Arsenal. We will find a current plan for this game,” Klopp said.”It’s always a big challenge to play against clubs like Arsenal or Manchester United.”It’s a good challenge, not easy, but really interesting. We have to make good decisions in the right moment. We are looking forward to these games. “My respect for Arsene Wenger grows day by day. It’s really intensive to work in the Premier League and he’s done a brilliant job.”Klopp’s remarks regarding Wenger, looking to lead Arsenal to a fourth league title but first since 2004, reflect his initial impressions of managing in England.Klopp, who took over at Anfield in October, said that the number of fixtures has been the biggest difference to managing on the continent, with Liverpool facing the possibility of playing nine games in January.That workload is stretching a squad that has been badly hit by injuries, although Klopp hopes to have a number of key players back for the game on Wednesday when the eighth-placed Reds will be looking for a third win in four league games.After having no senior central defenders available for last Friday’s 2-2 FA Cup draw at Exeter, ex-Arsenal defender Kolo Toure and Mamadou Sakho are both expected to be fit. Captain Jordan Henderson is also set to return in midfield and winger Jordon Ibe is fit after hamstring trouble.–last_img read more

Read more…